Causal Discovery Analysis: A Promising Tool for Precision Medicine

被引:1
|
作者
Bronstein, Michael [1 ,2 ,3 ]
Meyer-Kalos, Piper [1 ]
Vinogradov, Sophia [1 ]
Kummerfeld, Erich [2 ]
机构
[1] Univ Minnesota, Dept Psychiat & Behav Sci, Minneapolis, MN 55454 USA
[2] Univ Minnesota, Inst Hlth Informat, Minneapolis, MN 55454 USA
[3] Univ Minnesota, 2312 S 6th St,Fl 2,Ste F-275, Minneapolis, MN 55454 USA
关键词
D O I
10.3928/00485713-20240308-01
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Personalized treatment selection and planning rely on accurate hypotheses about the causes of clients' problems and the factors that hinder achievement of clients' recovery goals. Yet, accurately identifying these causal factors can be challenging because of practical considerations (eg, time pressure) and vulnerabilities in human cognition (eg, reasoning biases), particularly when clients' symptoms are nonspecific. Causal discovery analyses - an emerging class of machine -learning methods - provide a data -driven, potentially more accurate method of individualized case conceptualization and treatment selection/ evaluation. They can also be used to augment client insight, increase awareness to motivate willingness to change, and are a compelling visual aid for discussions of treatment rationale. This article provides an accessible introduction to these methods, with the goal of enabling clinicians to be informed partners when teaming with data scientists around measurement -based care and precision medicine. [Psychiatr Ann. 2024;54(4):e119 -e124.]
引用
下载
收藏
页码:e119 / e124
页数:6
相关论文
共 50 条
  • [1] Causal discovery analysis: A promising tool in advancing precision medicine for eating disorders
    Anderson, Lisa M.
    Lim, Kelvin O.
    Kummerfeld, Erich
    Crosby, Ross D.
    Crow, Scott J.
    Engel, Scott G.
    Forrest, Lauren
    Wonderlich, Stephen A.
    Peterson, Carol B.
    INTERNATIONAL JOURNAL OF EATING DISORDERS, 2023, 56 (11) : 2012 - 2021
  • [2] Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
    Jose C. Florez
    Diabetologia, 2017, 60 : 800 - 807
  • [3] Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
    Florez, Jose C.
    DIABETOLOGIA, 2017, 60 (05) : 800 - 807
  • [4] Precision Medicine Promising for AML
    Dolgin, Elie
    CANCER DISCOVERY, 2017, 7 (03) : 239 - 240
  • [5] SPME as a promising tool in translational medicine and drug discovery: From bench to bedside
    Gorynski, Krzysztof
    Gorynska, Paulina
    Gorska, Agnieszka
    Harezlak, Tomasz
    Jaroch, Alina
    Jaroch, Karol
    Lendor, Sofia
    Skobowiat, Cezary
    Bojko, Barbara
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2016, 130 : 55 - 67
  • [6] High-throughput base editing: a promising technology for precision medicine and drug discovery
    Sachinidis, Agapios
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [7] High-throughput base editing: a promising technology for precision medicine and drug discovery
    Agapios Sachinidis
    Signal Transduction and Targeted Therapy, 6
  • [8] Precision Medicine - Personalized, Problematic, and Promising
    Jameson, J. Larry
    Longo, Dan L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (23): : 2229 - 2234
  • [9] Gene Expression Profile Analysis for Drug Discovery and Precision Medicine
    Liu Yang
    Bai Hui
    Tao Huan
    He Song
    Huang Xin
    Bo Xiao-Chen
    Wang Sheng-Qi
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2016, 43 (10) : 923 - 935
  • [10] Causal machine learning for healthcare and precision medicine
    Sanchez, Pedro
    Voisey, Jeremy P.
    Xia, Tian
    Watson, Hannah I.
    O'Neil, Alison Q.
    Tsaftaris, Sotirios A.
    ROYAL SOCIETY OPEN SCIENCE, 2022, 9 (08):